T
TBPH
Theravance Bioph
16.39
+0.02+0.12%Opening09:30 05/26 EDT
OPEN/PREV CLOSE16.33/16.37
TODAY RANGE16.33-16.40
VOL5.45K
MARKET CAP844.95M
52 WEEK RANGE9.07-21.03
AVG VOL (3M)597.41K
% TURNOVER0.01%
TURNOVER--
P/E (TTM)7.44
% RANGE0.40%
EPS(TTM)2.204
P/E(FORWARD)8.28
P/B2.906
BVPS5.64
DIVIDEND--
P/S7.79
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP805.77M
SHARES OUTSTANDING51.55M
NEXT EARNINGS08/10-08/14
FREE FLOAT49.16M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·05/08 11:42
Theravance Biopharma (TBPH) Receives a Rating Update from a Top Analyst
TipRanks·05/07 20:41
Theravance Biopharma reports Q1 EPS (10c) vs. (17c) last year
Seeking Alpha·05/07 12:42
Theravance Biopharma GAAP EPS of -$0.10 misses by $0.13, revenue of $17.7M beats by $0.25M
Reuters·05/07 12:41
Ireland's Theravance Biopharma Q1 revenue beats estimates on YUPELRI growth
Reuters·05/07 12:30
BRIEF-Theravance Biopharma Q1 Operating Income USD -9.483 Million
NASDAQ·05/06 21:10
Xencor (XNCR) Reports Q1 Loss, Lags Revenue Estimates
NASDAQ·05/05 11:16
Theravance Biopharma Reaches Analyst Target Price
Seeking Alpha·04/29 15:26
Summers Value Fund adds TBPH, exits ADMA among Q1 moves
PUBT·04/28 21:20
Theravance Biopharma announces annual general meeting
Seeking Alpha·04/21 12:00
Theravance Biopharma: A Special Situation With A 50-100% Likely Upside
Seeking Alpha·04/10 14:24
Small-cap healthcare stocks with A+ grade EPS revisions ahead of earnings
Dow Jones·04/07 16:57
Theravance Biopharma Is Maintained at Neutral by B. Riley Securities